BT.. this is another exclusive one for you... please look into Cell Therapeutics... (Pixantrone)
Their Pixantrone drug is decent but due to bad management, they are still at current status. It was believed that they should be the next DNDN or HGSI..
in 2008/9, DNDN and HGSI rose enormously to the $20-30 range within a year, from $0.40ish..
Where was I when that happened?? NO CLUE!
Anyways... to cut the crap, here's the CTIC chart..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.